Pursuant to Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at its Meeting held today i.e., February 11, 2025, upon the recommendation of the Audit Committee, has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024

pdf

Sequent Scientific Ltd.

06 Feb 2025

181.88

-0.35%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has scheduled a conference call with the Analysts/Investors on Thursday, February 13, 2025, at 9.00 a.m. (I.S.T.) to discuss its Q3FY25 financial results. The Conference call details are enclosed herewith.

pdf

Sequent Scientific Ltd.

04 Feb 2025

181.88

-0.35%

Board Meeting

SEQUENT SCIENTIFIC LTD. - 512529 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Tuesday, February 11, 2025, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024

pdf